SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs rises on entering into share subscription agreement with Ethan Energy India

25 Nov 2022 Evaluate

Laurus Labs is currently trading at Rs. 457.90, up by 8.55 points or 1.90% from its previous closing of Rs. 449.35 on the BSE.

The scrip opened at Rs. 453.50 and has touched a high and low of Rs. 459.75 and Rs. 450.00 respectively. So far 32636 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 626.00 on 19-Apr-2022 and a 52 week low of Rs. 433.20 on 28-Jan-2022.

Last one week high and low of the scrip stood at Rs. 461.95 and Rs. 444.40 respectively. The current market cap of the company is Rs. 24616.43 crore.

The promoters holding in the company stood at 27.27%, while Institutions and Non-Institutions held 31.99% and 40.74% respectively.

Laurus Labs, as per the policy of the Government for captive consumption of power, has entered into Share Subscription agreement and Shareholders’ agreement on November 23, 2022 with Ethan Energy India for subscribing 7,40,000 Equity Shares of face value of Rs 10 each at a premium of Rs 42.70 which is equivalent to 26% of the paid up capital of Ethan Energy India. This will enable the Company to consume 100% of the solar energy to be supplied by Ethan Energy India from their 10 MW Solar Energy plant.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1161.80 -4.70 (-0.40%)
05-May-2026 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.80
Dr. Reddys Lab 1281.90
Cipla 1322.25
Zydus Lifesciences 909.90
Lupin 2351.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×